SynCardia Wins Copper Cactus Award for Innovation
and Two Best in Biz Awards
Best in Biz Awards Include: Product of the Year – Gold Winner, Executive of the Year – Silver Winner
TUCSON, Ariz. – Nov. 29, 2012 – SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total
Artificial Heart, announced today that it has been honored with three awards in
Best in Biz Awards, announced Nov. 12
- Best New Product of the Year
Gold Winner: Freedom® portable driver
The Freedom portable driver is the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart. Weighing 13.5 pounds, the Freedom portable driver allows stable Total Artificial Heart patients who meet discharge criteria to wait for a matching donor heart at home and in their communities instead of in the hospital.
- Executive of the Year
Silver Winner: Michael Garippa, SynCardia Chairman/CEO/President
Although many companies in the mechanical circulatory support industry are struggling to be profitable, SynCardia’s implants, revenue and profit for the first 9 months of 2012 have exceeded the company's best 12-month totals to date. In 2012, SynCardia is on track to achieve nearly 500% growth over 2009 thanks to Mr. Garippa’s leadership.
Winners were selected from more than 400 entries by an independent panel of 32 judges from top-tier news, business and technology publications, broadcast outlets and analyst firms, including ABC, Businessweek, Entrepreneur, Forbes, FOX News and USA Today.
Copper Cactus Awards, announced Nov. 13
- Nextrio Innovation through Technology Winner
As part of the Copper Cactus Awards presented by the Tucson Chamber of Commerce, SynCardia was honored for exceptional innovation through technology for its Freedom portable driver.
Since 2011, SynCardia has been honored with more than a dozen prestigious awards for its accomplishments in the fields of business, medicine and technology, including being ranked #20 among the "World's 50 Most Innovative Companies" by Fast Company Magazine and among "America's Most Promising Companies" by Forbes Magazine.
The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart.
Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.
More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.
SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by over 190 patients, accounting for over 110 years of support.